China (Mainland)
Moclobemide for depressive disorder CAS NO.71320-77-9
- Min.Order: 10 Gram
- Payment Terms: L/C,T/T,Other
- Product Details
Keywords
- Moclobemide
- purity 98% Moclobemide
- high quality cas 71320-77-9
Quick Details
- ProName: Moclobemide for depressive disorder
- CasNo: 71320-77-9
- Molecular Formula: C13H17ClN2O2
- Appearance: A white crystalline powder
- Application: Major depression. Social phobia in pa...
- DeliveryTime: within in 5-7 working days after recei...
- PackAge: 25kg/barrel or as customers' requireme...
- Port: Wuhan, Shanghai, Guangzhou, Tianjin po...
- ProductionCapacity: 200 Kilogram/Month
- Purity: ≥98.5%
- Storage: Stored below 25°C in a well-closed con...
- Transportation: by sea/by express
- LimitNum: 10 Gram
Superiority
Details
|
Name |
Moclobemide |
|---|---|
|
Type |
Small Molecule |
|
Groups |
Approved |
|
Description |
A reversible monoamine oxidase inhibitor (MAOI) selective for isoform A (RIMA) used to treat major depressive disorder. |
|
Structure |
|
|
Pharmacology |
|
|---|---|
|
Indication |
For the treatment of depression. |
|
Pharmacodynamics |
Moclobemide belongs to a class of MAOI antidepressants known as reversible inhibitors of monoamine oxidase type-A (RIMAs). The primary role of monoamine oxidase MAO lies in the metabolism of and regulation of the levels of monoamines (serotonin, norepinephrine, and dopamine). Within neurons, MAO appears to regulate the levels of monoamines released upon synaptic firing. Since depression is associated with low levels of monoamines, the inhibition of MAO serves to ease depressive symptoms. RIMAs demonstrate transient inhibition of the substrate binding site of MAO-A as well as competitive displacement from this site by bioamines. The RIMAs are distinguished from the older monoamine oxidase inhibitors (MAOIs) by their selectivity and reversibility. |
|
Mechanism of action |
The mechanism of action of moclobemide involves the selective, reversible inhibition of MAO-A. This inhibition leads to a decrease in the metabolism and destruction of monoamines in the neurotransmitters. This results in an increase in the monoamines, relieving depressive symptoms. |
|
Absorption |
Well absorbed from the gastrointestinal tract (> 95%). The presence of food reduces the rate but not the extent of absorption. Hepatic first pass metabolism reduces bioavailability to 45-70% following administration of a single dose, but increases to 80% with multiple dosing as a result of saturation of the first pass effect. Peak plasma concentrations are reached within 1 - 2 hours following oral administration. |
About us:
Hubei Jusheng Technology Co., Ltd., is a large group corporation which engaged in the R&D and manufacture of chemicals, Pharmaceuticals and intermediates. We have earned ourselves a good reputation at home and abroad with advanced technology, standardized management and well established service systerm. We have developed to a very famous group corporation Enterprise in chemical industry step by step.
Our main products:
Hormones, Dianabol , Testosterone blend , Sustanon 250 ,Trenbolone Acetate,test prop ,Nandrolone Decanoate , DECA , Deca-Durabolin , Equipoise EQ,Methenolone acetate, Primobolan,Stanozolol, Winstrol , winny, Oxandrolone ,Anavar ,Finaplix, Testosterone Enanthate, Methandienone , fat burner,Masteron, Sildenafil (Viagra), Tadalafil, Orlistat.